Comerica Bank’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.2M Sell
36,260
-206,849
-85% -$6.83M ﹤0.01% 1425
2025
Q1
$9.77M Buy
243,109
+7,645
+3% +$307K 0.04% 407
2024
Q4
$11.1M Sell
235,464
-1,558
-0.7% -$73.3K 0.04% 383
2024
Q3
$12.5M Buy
237,022
+70,842
+43% +$3.74M 0.05% 358
2024
Q2
$9M Buy
166,180
+35,374
+27% +$1.92M 0.04% 430
2024
Q1
$9.17M Buy
130,806
+84,967
+185% +$5.96M 0.04% 445
2023
Q4
$3.83M Buy
45,839
+940
+2% +$78.5K 0.02% 828
2023
Q3
$1.32M Buy
+44,899
New +$1.32M 0.01% 1289
2022
Q4
$2.4M Sell
56,094
-15,935
-22% -$681K 0.02% 978
2022
Q3
$3.25M Sell
72,029
-955
-1% -$43.1K 0.03% 741
2022
Q2
$2.92M Buy
72,984
+2,267
+3% +$90.6K 0.02% 842
2022
Q1
$2.67M Buy
70,717
+905
+1% +$34.2K 0.02% 968
2021
Q4
$2.13M Sell
69,812
-5,743
-8% -$175K 0.02% 1120
2021
Q3
$2.8M Buy
75,555
+8,645
+13% +$320K 0.02% 1073
2021
Q2
$2.01M Sell
66,910
-4,720
-7% -$142K 0.01% 1310
2021
Q1
$1.9M Sell
71,630
-2,373
-3% -$62.8K 0.01% 1383
2020
Q4
$1.51M Buy
74,003
+475
+0.6% +$9.67K 0.01% 1478
2020
Q3
$1.21M Buy
73,528
+10,834
+17% +$178K 0.01% 1445
2020
Q2
$1.5M Buy
62,694
+5,471
+10% +$131K 0.01% 1262
2020
Q1
$897K Buy
57,223
+2,159
+4% +$33.8K 0.01% 1417
2019
Q4
$708K Buy
55,064
+295
+0.5% +$3.79K 0.01% 1733
2019
Q3
$608K Buy
54,769
+944
+2% +$10.5K ﹤0.01% 1790
2019
Q2
$624K Sell
53,825
-329
-0.6% -$3.81K 0.01% 1784
2019
Q1
$472K Buy
54,154
+1,808
+3% +$15.8K ﹤0.01% 1906
2018
Q4
$357K Sell
52,346
-228
-0.4% -$1.56K ﹤0.01% 1996
2018
Q3
$380K Sell
52,574
-521
-1% -$3.77K ﹤0.01% 1992
2018
Q2
$467K Buy
53,095
+609
+1% +$5.36K ﹤0.01% 1950
2018
Q1
$373K Buy
52,486
+998
+2% +$7.09K ﹤0.01% 2003
2017
Q4
$499K Sell
51,488
-1,566
-3% -$15.2K ﹤0.01% 1928
2017
Q3
$737K Buy
53,054
+5,192
+11% +$72.1K 0.01% 1748
2017
Q2
$689K Buy
+47,862
New +$689K 0.01% 1728